Abstract
Endocrine treatment for breast cancer acts largely by inhibiting tumor cell proliferation. This study aimed to determine the efficacy of short-term neoadjuvant endocrine therapy by response on Ki67-index in early-stage breast cancer.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
